The von Hippel–Lindau tumour suppressor protein: new perspectives

This publication has 40 references indexed in Scilit:

• pVHL ₁₉ is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
  Proceedings of the National Academy of Sciences, 1998
• A second major native von Hippel–Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor
  Proceedings of the National Academy of Sciences, 1998
• Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
  Human Mutation, 1998
• von Hippel-Lindau Disease
  Medicine, 1997
• Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice
  Proceedings of the National Academy of Sciences, 1997
• Lessons from Hereditary Colorectal Cancer
  Cell, 1996
• Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis
  Human Molecular Genetics, 1996
• Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan
  Human Mutation, 1996
• Mutations of the VHL tumour suppressor gene in renal carcinoma
  Nature Genetics, 1994
• Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
  Science, 1993